Drug Side Effects
Search
DIFFUSE UVEAL MELANOCYTIC PROLIFERATION
DIFFUSE UVEAL MELANOCYTIC PROLIFERATION
was reported 19 times
DIFFUSE UVEAL MELANOCYTIC PROLIFERATION is most prevalent among patients taking these drugs:
#
Drug
Count
Frequency
0
DORZOLAMIDE HCL
1
0.0009
1
CEMIPLIMAB-RWLC
1
0.0005
2
DURVALUMAB
6
0.0003
3
LOTEPREDNOL ETABONATE
1
0.0002
4
DORZOLAMIDE
1
0.0001
5
TRAVOPROST
1
0.0001
6
PEMBROLIZUMAB
8
0.0001
7
NINTEDANIB
2
0.0001
8
BRIMONIDINE TARTRATE
1
0.0001
9
CALCITRIOL CAPSULES 0.25 MCG
1
0.0000
10
SODIUM BICARBONATE INJECTION,
1
0.0000
11
LINACLOTIDE
1
0.0000
12
ERGOCALCIFEROL
1
0.0000
13
CETUXIMAB
1
0.0000
14
SUNITINIB MALATE
1
0.0000
15
MAGNESIUM OXIDE
1
0.0000
16
IPILIMUMAB
1
0.0000
17
PACLITAXEL
2
0.0000
18
BEVACIZUMAB
2
0.0000
19
CARBOPLATIN
2
0.0000
20
CALCIUM CARBONATE
1
0.0000
21
EZETIMIBE
1
0.0000
22
DOXORUBICIN
1
0.0000
23
NIVOLUMAB
1
0.0000
24
WARFARIN
1
0.0000
25
TACROLIMUS OINTMENT 0.1%
1
0.0000
26
TACROLIMUS EXTENDED-RELEASE CAPSULES
1
0.0000
27
VENLAFAXINE HYDROCHLORIDE
1
0.0000
28
MYCOPHENOLATE MOFETIL
1
0.0000
29
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
1
0.0000
30
ESCITALOPRAM
1
0.0000
31
TACROLIMUS
1
0.0000
32
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE
1
0.0000
33
METOPROLOL TARTRATE
1
0.0000
34
GABAPENTIN
1
0.0000
35
OMEPRAZOLE MAGNESIUM
1
0.0000
36
ACETAMINOPHEN
1
0.0000
37
PREDNISONE
1
0.0000